Nonprofit · EIN 22-2990719
SOCIETY FOR VASCULAR SURGERY
Tax-exempt · ROSEMONT, IL 60018
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| March 31, 2025 | 990 | $15,325,281 | $17,085,599 | -$1,760,318 | $27,048,949 | $10,337,132 | $16,711,817 |
| March 31, 2024 | 990 | $14,766,161 | $14,764,215 | $1,946 | $27,787,589 | $9,574,432 | $18,213,157 |
| March 31, 2023 | 990 | $14,367,638 | $13,745,378 | $622,260 | $26,706,213 | $9,269,294 | $17,436,919 |
Financial details: 990 for the year ended March 31, 2025
Revenue
- Contributions, gifts and grants
- $1,517,807
- Program service revenue
- $12,623,525
- Investment income
- $832,682
- Royalties
- $252,292
- Net gain from sales of assets
- $180,117
- Other revenue
- $351,267
Expenses
- Grants and similar amounts paid
- $205,095
- Compensation of officers, directors and key employees
- $708,944
- Other salaries and wages
- $5,200,277
- Salaries, compensation and benefits (total)
- $7,230,586
- Professional fundraising fees
- $0
- Legal fees
- $73,383
- Accounting fees
- $38,835
- Occupancy
- $407,271
- Travel
- $379,738
- Depreciation
- $909,705
Balance sheet and other
- Total assets, start of year
- $27,787,589
- Total assets, end of year
- $27,048,949
- Total liabilities, end of year
- $10,337,132
- Net assets, end of year
- $16,711,817
- Land, buildings and equipment
- $1,134,442
- Publicly traded securities
- $8,561,216
- Net assets without donor restrictions
- $16,282,427
- Net assets with donor restrictions
- $429,390
- Gross unrelated business income
- $184,007
- Gross receipts
- $17,651,235
- Employees
- 62
- Volunteers
- 554
- Year formed
- 1947
- State of legal domicile
- IL
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended March 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KENNETH M SLAW PHD | EXECUTIVE DIRECTOR Officer | 37.5 | $411,645 | $41,751 |
| JIM WADZINSKI | DEPUTY EXECUTIVE DIRECTOR Key employee | 37.5 | $243,194 | $12,354 |
| MEGAN MARCINKO | SENIOR DIRECTOR OF ADVOCAC Highest-paid employee | 37.5 | $206,018 | $10,301 |
| SARAH MURPHY | DIRECTOR OF RESEARCH Highest-paid employee | 37.5 | $171,692 | $26,853 |
| KEVIN ONORATO | IT DIRECTOR Highest-paid employee | 37.5 | $171,790 | $18,934 |
| SHRAVAN ANIMILLI | DIRECTOR OF ANALYTICS AND DATA SCIENCE Highest-paid employee | 37.5 | $144,200 | $33,725 |
| JANINE DIANA | HUMAN RESOURCES DIRECTOR Highest-paid employee | 37.5 | $143,696 | $18,521 |
| KEITH D CALLIGARO MD | PRESIDENT-ELECT Trustee or director, Officer | 2 | $0 | $0 |
| MATTHEW J EAGLETON MD | PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| ROBERT G MOLNAR MD | AT LRG MEMBER Trustee or director | 1 | $0 | $0 |
| BERNADETTE AULIVOLA MD | AT LRG MEMBER Trustee or director | 1 | $0 | $0 |
| LINDA M HARRIS MD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| WILLIAM P SHUTZE MD | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| KWAME S AMANKWAH MD | AT LRG MEMBER Trustee or director | 1 | $0 | $0 |
| KELLIE R BROWN MD | AT LRG MEMBER Trustee or director | 1 | $0 | $0 |
3 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| AUDRA A DUNCAN MD | AT LRG MEMBER Trustee or director | 1 | $0 |
| THOMAS L FORBES MD | TREASURER Trustee or director, Officer | 2 | $0 |
| JOSEPH L MILLS MD | IMMEDIATE PAST-PRESIDENT Trustee or director, Officer | 2 | $0 |
990 for the year ended March 31, 2024: 19 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KENNETH M SLAW PHD | EXECUTIVE DIRECTOR Officer | 37.5 | $401,450 | $42,585 |
| JIM WADZINSKI | DEPUTY EXECUTIVE DIRECTOR Key employee | 37.5 | $238,371 | $13,699 |
| MEGAN MARCINKO | SENIOR DIRECTOR OF ADVOCACY Highest-paid employee | 37.5 | $195,152 | $9,933 |
| SARAH MURPHY | DIRECTOR OF RESEARCH Highest-paid employee | 37.5 | $169,404 | $27,694 |
| KEVIN ONORATO | IT DIRECTOR Highest-paid employee | 37.5 | $159,705 | $19,875 |
| RUPA BROSSEAU | DEPUTY EXECUTIVE DIRECTOR Highest-paid employee | 5 | $165,600 | $7,926 |
| KATHERINE MOCARSKI | DIRECTOR OF FINANCE Highest-paid employee | 37.5 | $137,187 | $18,690 |
| MICHAEL C DALSING MD | IMMEDIATE PAST PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| BERNADETTE AULIVOLA MD | MEMBER Trustee or director, Officer | 2 | $0 | $0 |
| JOSEPH L MILLS MD | PRESIDENT Trustee or director, Officer | 3 | $0 | $0 |
| MATTHEW J EAGLETON MD | PRESIDENT-ELECT Trustee or director, Officer | 3 | $0 | $0 |
| WILLIAM P SHUTZE MD | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| KEITH D CALLIGARO MD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| KWAME S AMANKWAH MD | LIAISON Trustee or director | 2 | $0 | $0 |
| KELLIE R BROWN MD | LIAISON Trustee or director | 2 | $0 | $0 |
| ANDRES SCHANZER MD | CHAIR Trustee or director | 2 | $0 | $0 |
| ROBERT G MOLNAR MD | CHAIR Trustee or director | 2 | $0 | $0 |
| AUDRA A DUNCAN MD | LIAISON Trustee or director | 2 | $0 | $0 |
| THOMAS L FORBES MD | TREASURER Trustee or director, Officer | 2 | $0 | $0 |
990 for the year ended March 31, 2023: 17 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| KENNETH M SLAW PHD | EXECUTIVE DIRECTOR Officer | 37.5 | $378,581 | $38,471 |
| JAMES WADZINSKI | DEPUTY EXECUTIVE DIRECTOR Key employee | 37.5 | $216,342 | $11,874 |
| KRISTOPHER HUFFMAN | DIRECTOR OF ANALYTICS Highest-paid employee | 37.5 | $153,785 | $17,776 |
| KEVIN ONORATO | IT DIRECTOR Highest-paid employee | 37.5 | $149,917 | $17,541 |
| SARAH MURPHY | DIRECTOR OF RESEARCH Highest-paid employee | 37.5 | $137,604 | $21,390 |
| RUPA BROSSEAU | DEPUTY EXECUTIVE DIRECTOR Highest-paid employee | 5 | $143,606 | $7,152 |
| KATHERINE MOCARSKI | DIRECTOR OF FINANCE Highest-paid employee | 37.5 | $130,070 | $16,464 |
| ANDRES SCHANZER MD | MEMBER Trustee or director | 2 | $15,000 | $0 |
| KEITH D CALLIGARO MD | TREASURER Trustee or director, Officer | 2 | $1,826 | $0 |
| MICHAEL C DALSING MD | PRESIDENT Trustee or director, Officer | 3 | $0 | $0 |
| ALI F ABURAHMA MD | IMMEDIATE PAST PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| JOSEPH L MILLS MD | PRESIDENT-ELECT Trustee or director, Officer | 2 | $0 | $0 |
| MATTHEW J EAGLETON MD | VICE PRESIDENT Trustee or director, Officer | 2 | $0 | $0 |
| WILLIAM P SCHUTZE MD | SECRETARY Trustee or director, Officer | 2 | $0 | $0 |
| VINCENT L ROWE MD | LIAISON Trustee or director | 2 | $0 | $0 |
| PALMA M SHAW MD | LIAISON Trustee or director | 2 | $0 | $0 |
| ROBERT G MOLNAR MD | MEMBER Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 9400 W HIGGINS RD STE 315, ROSEMONT, IL 60018-4975
- Principal officer (990 for 2024)
- KENNETH M SLAW PHD, 9400 W HIGGINS RD SUITE 315, ROSEMONT, IL 60018
- Signed the 990
- KENNETH M SLAW PHD, EXECUTIVE DIRECTOR
- Phone
- (312) 334-2319
- Website
- HTTPS://VASCULAR.ORG
- Return prepared by
- CLIFTONLARSONALLEN LLP
Mission
TO IMPROVE THE PREVENTION, DIAGNOSIS, AND MANAGEMENT OF PATIENTS WITHVASCULAR DISEASE BY PROMOTING CLINICAL AND BASIC RESEARCH; PROVIDINGCONTINUING EDUCATION; DEVELOPING POST-GRADUATE TRAINING; ADVOCATING ONBEHALF OF MEMBERS; PROMOTING THE DEVELOPMENT AND IMPLEMENTATION OF NEWTECHNOLOGY; PROMOTING AND FACILITATING THE DISSEMINATION OF KNOWLEDGEAND INFORMATION TO PRACTITIONERS, PATIENTS, AND THE PUBLIC;STANDARDIZING NOMENCLATURE AND REPORTING OF VASCULAR CONDITIONS;DEVELOPING PRACTICE STATEMENTS AND GUIDELINES; AND ADDRESSING RELATEDSOCIAL, ECONOMIC, ETHICAL, AND LEGAL ISSUES.
Program accomplishments
- EDUCATION - SVS HOSTS AN ANNUAL MEETING AND TRADE SHOW TO PROMOTE THE STUDY AND RESEARCH OF VASCULAR DISEASES, DEFINE THE ROLE OF VASCULAR SURGERY, AND STANDARDIZE THE METHODS OF STUDY. IN ADDITION, SVS OFFERS EDUCATIONAL COURSES AND PROGRAMS TO PROMOTE THE STUDY OF VASCULAR DISEASES, EXPAND KNOWLEDGE OF SUCH DISEASES, AND ENCOURAGE GROWTH IN THE FIELD.
- QUALITY PRACTICE - SOUGHT IMPROVEMENT OF PATIENT SAFETY AND QUALITY OF HEALTH CARE DELIVERY BY PROVIDING WEB-BASED COLLECTION, AGGREGATION, AND ANALYSIS OF CLINICAL DATA.
- PUBLICATIONS - THE JOURNAL OF VASCULAR SURGERY IS DEDICATED TO THE SCIENCE AND ART OF VASCULAR SURGERY AND AIMS TO BE THE PREMIER INTERNATIONAL JOURNAL OF MEDICAL ENDOVASCULAR AND SURGICAL CARE OF VASCULAR DISEASES. THE GOAL OF THE JOURNAL IS TO IMPROVE THE MANAGEMENT OF PATIENTS WITH VASCULAR DISEASES BY PUBLISHING RELEVANT PAPERS THAT REPORT MEDICAL, SURGICAL, AND ENDOVASCULAR ADVANCES, TEST NEW HYPOTHESES, AND ADDRESS CURRENT CONTROVERSIES.
- RESEARCH - ENCOURAGE THE INTEREST AND DEVELOPMENT OF INVESTIGATORS BY PROVIDING A FORUM FOR COLLABORATION AND DISSEMINATION OF ADVANCEMENTS IN OUTCOMES, COMPARATIVE EFFECTIVENESS, CLINICAL, TRANSLATIONAL, AND BASIC SCIENCE RESEARCH.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in March, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | March 31, 2026 | August 17, 2026 | Not on file |
| 2024 | March 31, 2025 | August 15, 2025 | 990 on file |
| 2023 | March 31, 2024 | August 15, 2024 | 990 on file |
IRS record
- EIN
- 22-2990719
- Tax-exempt status
- 501(c)(6): Business league or chamber of commerce
- Exempt since
- 1987
- Accounting year ends
- March
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $27,048,949
- Income (IRS master file)
- $17,651,235
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | March 2025 | $15,325,281 | $17,085,599 | $27,048,949 | XML |
| 990 | March 2024 | $14,766,161 | $14,764,215 | $27,787,589 | XML |
| 990 | March 2023 | $14,367,638 | $13,745,378 | $26,706,213 | XML |
| 990 | March 2022 | $12,701,709 | $12,291,878 | $23,352,063 | IRS |
| 990 | March 2021 | – | – | – | IRS |
| 990 | March 2020 | – | – | – | IRS |
| 990 | March 2019 | – | – | – | IRS |
| 990 | March 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 22-2990719).
Questions about SOCIETY FOR VASCULAR SURGERY
- What is the EIN of SOCIETY FOR VASCULAR SURGERY?
- The employer identification number (EIN) of SOCIETY FOR VASCULAR SURGERY is 22-2990719.
- Is SOCIETY FOR VASCULAR SURGERY tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 1987.
- Which annual return does SOCIETY FOR VASCULAR SURGERY file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of SOCIETY FOR VASCULAR SURGERY due?
- The return for tax year 2025 (the year ending March 31, 2026) is due August 17, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did SOCIETY FOR VASCULAR SURGERY last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended March 2025.
- Who is the principal officer of SOCIETY FOR VASCULAR SURGERY?
- The 990 for the year ended March 31, 2025 names KENNETH M SLAW PHD.
- Who are the officers and directors of SOCIETY FOR VASCULAR SURGERY?
- The 990 for the year ended March 31, 2025 lists 18 people; 7 received compensation from the organization, the highest $411,645 (KENNETH M SLAW PHD, EXECUTIVE DIRECTOR).
- How much revenue does SOCIETY FOR VASCULAR SURGERY have?
- On its 990 for the year ended March 31, 2025 it reported revenue of $15,325,281, expenses of $17,085,599 and total assets of $27,048,949 at year end.
Other nonprofits in ROSEMONT
- BIG TEN CONFERENCE INC EIN 36-3640583 · last filed 990 for 2025
- DAIRY MANAGEMENT INC EIN 36-3992031 · last filed 990 for 2024
- NATIONAL MILK PRODUCERS FEDERATION EIN 53-0115160 · last filed 990 for 2024
- AMERICAN ACADEMY OF DERMATOLOGY INC EIN 41-0793046 · last filed 990 for 2024
- AMERICAN ACADEMY OF ORTHOPEDIC SURGEONS EIN 36-2110592 · last filed 990 for 2024
- UNITED DAIRY INDUSTRY ASSOCIATION INC EIN 36-2702849 · last filed 990 for 2024
- AMERICAN ASSOCIATION OF ORTHOPAEDIC SURGEONS OF AMERICA EIN 36-4241052 · last filed 990 for 2024
- AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS EIN 36-2405828 · last filed 990 for 2025